Jodie Sherman Gillon rejoined Pfizer as the Global Medical Lead, Patient Engagement for Rare Disease. She most recently served as the Head of Patient Advocacy and Professional Affairs with Achillion, a small Rare disease Pharma. As the sole FTE in Medical Affairs, Jodie was primarily responsible for Policy, Alliances, Patient Engagement, Contributions/Grants, Compassionate Use, Medical Information, Medical Communications, Field Medical, and management of Meetings and HCP engagements. Previously she served as the Head of the Chief Medical Office (CMO) of AstraZeneca. As Head of the CMO, Jodie managed Patient Engagement, Compassionate Use, Trial and Payment Transparency, Meetings and Events, an HCP Engagement Center, companywide policy, financial contributions, alliances, crisis management and gatekeeping. She represented AZ externally on committees such as PHRMA, EFPIA, NIH, FDA, IOM and the CMO roundtable.
For nine years prior to AZ, Jodie served as the Director, External Medical Communications with Pfizer. In addition to overseeing Communications for the Specialty Care and Emerging Markets Business units, she led an External Collaborations Alliance focused on academic centers, publishing companies, societies and thought leaders. As part of Pfizer’s Transparency team, she played a pivotal role in implementing the PhRMA/EFPIA Principles and integrating vendors and systems after the Wyeth merger.
Prior to Pfizer, Jodie was a Global Communications lead at Novartis and managed a Phase IV/IIR review board. She served as the Director of Medical Education for Oridion Medical and as a Health Economist with the Israeli Center for Disease Control and Ministry of Health. She has held additional roles in academia, advocacy and the White House. Jodie holds a Master’s of Public Health with a dual degree in Health Economics and Epidemiology and a BSFS from Georgetown’s School of Foreign Service.
You may contact her at Jodie.Gillon@Pfizer.com